https://www.epo.org/fr/boards-of-appeal/decisions/t930915eu1
T 0915/93 (Monoclonal antibody therapy/ORTHO) du 22.04.1994
monoclonal antibody therapy22 04091593
https://www.houstonmethodist.org/leading-medicine-blog/articles/2021/aug/monoclonal-antibody-therapy-for-covid-19/
Monoclonal Antibody Therapy for COVID-19 | Houston Methodist Leading Medicine Blog
Vaccination remains the top COVID-19 priority, but monoclonal antibodies are also a valuable tool, says a Houston Methodist doctor
monoclonal antibody therapycovid 19houston methodist
https://www.fda.gov/drugs/drug-alerts-and-statements/fda-authorizes-regen-cov-monoclonal-antibody-therapy-post-exposure-prophylaxis-prevention-covid-19
FDA authorizes REGEN-COV monoclonal antibody therapy for post-exposure prophylaxis (prevention) for...
FDA revised the emergency use authorization (EUA) for REGEN-COV (casirivimab and imdevimab, administered together) authorizing REGEN-COV for emergency use as...
monoclonal antibody therapypost exposure prophylaxisregen cov
https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1527102/full
Frontiers | Switching to ublituximab from prior anti-CD20 monoclonal antibody therapy: a case...
IntroductionAnti-CD20 monoclonal antibody (mAb) therapies used to treat multiple sclerosis (MS) differ in their molecular structures, epitope recognition, an...